Drake & Associates’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
Drake & Associates's ABT Position: Q3 2026 in Review
Drake & Associates reduced its Abbott (ABT) stake by 0.86% in Q3 2026, selling an estimated $6.58K and leaving 7,267 shares worth $718K. The position accounts for 0.11% of the portfolio, ranked #56.
Drake & Associates first reported a position in ABT in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.27M in Q3 2025. 3,040 funds tracked by Wall St. Rank hold ABT as of Q3 2026.
- Drake & Associates held 7,267 shares of Abbott worth $718K as of Q3 2026.
- Drake & Associates sold 63 Abbott shares in Q3 2026, an estimated $6.58K.
- Abbott made up 0.11% of Drake & Associates's portfolio in Q3 2026, its #56 holding.
- Drake & Associates first reported a position in Abbott in Q4 2022 and has held it in 16 quarters since.
- Drake & Associates's Abbott position peaked at $1.27M in Q3 2025.
- 3,040 funds tracked by Wall St. Rank held Abbott as of Q3 2026.
Based on Drake & Associates's 13F filing for Q3 2026, filed 18 Nov 2026.